Table 3.
Laboratory data.
| Parameters | Control subjects | Patients with DN | P Value |
|---|---|---|---|
| (N = 12) | (N = 19) | ||
| BG, mg/dl | 93.2 ± 4.6 | 170.5 ± 12.3* | 0.0003 |
| HbA1c, % | (N/A) | 8.1 ± 0.5 | (N/A) |
| T-Cho, mg/dl | 190.4 ± 14.0 | 250.4 ± 15.2* | 0.0119 |
| TG, mg/dl | 165.3 ± 48.1 | 309.0 ± 55.8* | 0.0106 |
| HDL, mg/dl | 64.5 ± 5.3 | 50.5 ± 2.3* | 0.0200 |
| LDL, mg/dl | 95.6 ± 10.9 | 135.9 ± 15.7 | 0.0891 |
| UNA, g/day | 2.2 ± 0.2 | 2.3 ± 0.2 | 0.8702 |
| UCl, g/day | 3.2 ± 0.4 | 3.0 ± 0.4 | 0.6238 |
| UNaCl, g/day | 5.4 ± 0.6 | 5.3 ± 0.6 | 0.7855 |
| UPro, mg/day | 91.7 ± 24.4 | 4078.2 ± 928.8* | < 0.0001 |
| Serum Cr, mg/dl | 0.6 ± 0.04 | 1.1 ± 0.2* | 0.0166 |
| eGFR, mL/min/per 1.73 m2 | 97.8 ± 6.1 | 68.3 ± 8.9* | 0.0219 |
HbA1c was measured according to the method of the Japan Diabetes Society (JDS) unit. DN indicates diabetic nephropathy; BG, blood glucose; HbA1c, hemoglobin A1c; T-Cho, total cholesterol; TG, triglyceride; HDL, high density lipoprotein; LDL, low density lipoprotein; UNA, urinary sodium excretion; UCl, urinary chloride excretion; UNaCl, urinary sodium chloride excretion; UPro, urinary protein excretion; Cr, creatinine; eGFR, estimated glomerular filtration rate. * P < 0.05 vs. control subjects.